Aveo Stock Plunge Fair Game When Ex-CFO Stands Trial
The government can tell a jury about how the stock price of an Aveo Pharmaceuticals cancer drug plummeted 31 percent after the public learned the U.S. Food and Drug Administration had...To view the full article, register now.
Already a subscriber? Click here to view full article